一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Journal of Advanced Research >>article
Journal of Advanced Research

Journal of Advanced Research

IF: 11.4
Download PDF

An interpretable artificial intelligence framework for designing synthetic lethality-based anti-cancer combination therapies

Published:2 December 2023 DOI: 10.1016/j.jare.2023.11.035

Abstract

Introduction

Synthetic lethality (SL) provides an opportunity to leverage different genetic interactions when designing synergistic combination therapies. To further explore SL-based combination therapies for cancer treatment, it is important to identify and mechanistically characterize more SL interactions. Artificial intelligence (AI) methods have recently been proposed for SL prediction, but the results of these models are often not interpretable such that deriving the underlying mechanism can be challenging.

Objectives

This study aims to develop an interpretable AI framework for SL prediction and subsequently utilize it to design SL-based synergistic combination therapies.

Methods

We propose a knowledge and data dual-driven AI framework for SL prediction (KDDSL). Specifically, we use gene knowledge related to the SL mechanism to guide the construction of the model and develop a method to identify the most relevant gene knowledge for the predicted results.

Results

Experimental and literature-based validation confirmed a good balance between predictive and interpretable ability when using KDDSL. Moreover, we demonstrated that KDDSL could help to discover promising drug combinations and clarify associated biological processes, such as the combination of MDM2 and CDK9 inhibitors, which exhibited significant anti-cancer effects in vitro and in vivo.

Conclusion

These data underscore the potential of KDDSL to guide SL-based combination therapy design. There is a need for biomedicine-focused AI strategies to combine rational biological knowledge with developed models.

Substances (14)

Materials Related products
Procduct Name CAS Molecular Formula Supplier Price
VH298 2097381-85-4 C27H33N5O4S 122 suppliers $37.00-$4741.00
VH298 2097381-85-4 C27H33N5O4S 122 suppliers $37.00-$4741.00
VH298 2097381-85-4 C27H33N5O4S 122 suppliers $37.00-$4741.00
VH298 2097381-85-4 C27H33N5O4S 122 suppliers $37.00-$4741.00
4-((5'-chloro-2'-((1R,4r)-4-((R)-1-methoxypropan-2-ylamino)cyclohexylamino)-2,4'-bipyridin-6-ylamino)methyl)tetrahydro-2H-pyran-4-carbonitrile 1263373-43-8 C27H37ClN6O2 86 suppliers Inquiry
4-((5'-chloro-2'-((1R,4r)-4-((R)-1-methoxypropan-2-ylamino)cyclohexylamino)-2,4'-bipyridin-6-ylamino)methyl)tetrahydro-2H-pyran-4-carbonitrile 1263373-43-8 C27H37ClN6O2 86 suppliers Inquiry
4-((5'-chloro-2'-((1R,4r)-4-((R)-1-methoxypropan-2-ylamino)cyclohexylamino)-2,4'-bipyridin-6-ylamino)methyl)tetrahydro-2H-pyran-4-carbonitrile 1263373-43-8 C27H37ClN6O2 86 suppliers Inquiry
4-((5'-chloro-2'-((1R,4r)-4-((R)-1-methoxypropan-2-ylamino)cyclohexylamino)-2,4'-bipyridin-6-ylamino)methyl)tetrahydro-2H-pyran-4-carbonitrile 1263373-43-8 C27H37ClN6O2 86 suppliers Inquiry
ZM 323881 hydrochloride 193000-39-4 C22H19ClFN3O2 78 suppliers $32.00-$1500.00
ZM 323881 hydrochloride 193000-39-4 C22H19ClFN3O2 78 suppliers $32.00-$1500.00

Similar articles

IF:6.1

Polyethyleneimine-based immunoadjuvants for designing cancer vaccines

Journal of Materials Chemistry B Xi Yang, Yuanfeng Wei,etc Published: 11 October 2022
IF:5.4

Designing and Constructing a Novel Artificial Pathway for Malonic Acid Production Biologically.

ACS Applied Energy Materials Shuying Gu, Zhen Zhao,etc Published: 19 January 2022
IF:1.5

Synthetic strategies for preparation of cyclen-based MRI contrast agents

Tetrahedron Letters Nevenka Caki?, Serhat Gündüz,etc Published: 4 February 2015
富平县| 荃湾区| 平安县| 阿拉善盟| 双辽市| 东乡族自治县| 呼图壁县| 监利县| 札达县| 桂阳县| 平度市| 吐鲁番市| 定边县| 大庆市| 广州市| 马关县| 长阳| 铁力市| 栖霞市| 远安县| 卢氏县| 泰兴市| 南宫市| 奈曼旗| 惠水县| 呼伦贝尔市| 隆尧县| 平舆县| 南汇区| 廊坊市| 乡城县| 崇义县| 唐山市| 兴安盟| 岑巩县| 乐陵市| 阜新| 双鸭山市| 广西| 余江县| 清镇市|